In silico design of potent inhibitors targeting TNF-alpha, IL-1β, and TGF-β of inflammatory disease using QSAR, docking, MD simulation, ADMET, and DFT studies
2025Letters in Drug Design & DiscoveryJournalOpen access
10.1016/j.lddd.2025.100203Full text2 citations